|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Developmental pharmacology: drug disposition, action, and therapy in infants and children 显示文摘 | Kearns GL Abdel-Rahman SM Alander SW Blowey DL Leeder JS Kauffman RE | 2003 | N Engl J Med2003，349，12： | 1 |
| 2 | Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs 显示文摘 | Leeder JS | 1998 | Epilepsia1998，39，7： | 1 |
| 3 | Developmental and pediatric pharmacogenomics显示文摘 | Leeder JS | 2003 | Pharmacogenomics2003，4，3： | 1 |
| 4 | Developmental pharmacology-drug disposition,action,and therapy in infants and children显示文摘 | Kearns GL Abdel-Rahman SM Alander SW Blowey DL Leeder JS Kauffman RE | 2003 | N Engl J Med2003，349，12： | 1 |
| 5 | Cytochrome P450 3A: ontogeny and drug disposition显示文摘 | de Wildt SN Kearns GL Leeder JS | 1999 | Clin Pharmacokinet1999，37，6： | 1 |
| 6 | Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the 'Cooperstown 5 + 1 cocktail' 显示文摘 | Chainuvati S Nafziger AN Leeder JS | 2003 | Clin Pharmacol Ther2003，74，： | 1 |
| 7 | Pharmacogenetics and pharmacogenomics显示文摘 | | 2001 | Pediatr Clin North Am2001，48，3： | 1 |
| 8 | Developmental and pediatric pharmacogenomics显示文摘 | | 2003 | Pharmacogenomics2003，4，3： | 1 |
| 9 | Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data显示文摘 | Gaedigk A Gotschall PR Forbes NS Simon SD Kearns GL Leeder JS | 1999 | Pharmacogenetics1999，9，： | 1 |
| 10 | Acetaminophen in- toxication during treatment, what you don't know can hurt you显示文摘 | Kearns GL Leeder JS Wasserman GS | 2000 | Clinical Pediatrics2000，39，3： | 1 |
| 11 | P4503A: Ontogeny and drug disposition 显示文摘 | Wildt SN Kearns GL Leeder JS | 1999 | Clin Pharmacokinet1999，37，6： | 1 |
| 12 | Developmental and pediatric pharmacogenomics显示文摘 | Leeder JS | 2003 | Pharmacogenomics2003，4，3： | 1 |
| 13 | Cytoehrome P450 3A : ontogeny and drug disposition 显示文摘 | De Wildt SN Keams GL Leeder JS | 1999 | Clin Pharmacokinet1999，37，6： | 1 |
| 14 | Cytochrome P450 3A:ontogeny and drug disposition显示文摘 | Kearns GL Leeder JS | 1999 | Clin Pharmacokinet1999，37，6： | 1 |
| 15 | Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non CYP2D6 pathways on biotransformation 显示文摘 | Abdel-Rahman SM Leeder JS Wilson JT | 2002 | J Clin Pharmacol2002，42，1： | 1 |
| 16 | Biotransformation of fluticasone:in vitro characterization显示文摘 | Dearce RE Leeder JS Kearns GL | 2006 | Durg Metab Dispos2006，34，6： | 1 |
| 17 | Developmental and pediatric pharmacogenomics 显示文摘 | Leeder JS | 2003 | Pharmacogenomics2003，4，3： | 1 |
| 18 | Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptie drugs显示文摘 | | 1998 | Epilepsia1998，39，7： | 1 |
| 19 | The challenges of delivering pharmacogenomics into clinical pediatrics 显示文摘 | Keams GL | 2002 | Pharmacogenomics J2002，2，3： | 1 |
| 20 | Variability of CYP3 A7 expression in human fetal liver显示文摘 | Leeder JS Gaedigk R Marcucci KA | 2005 | J Pharmacol Exp Therapeutics2005，314，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员